**Question:** A patient having glaucoma develops blepharoconjunctivitis after instilling some anti-glaucoma drug. Which of the following drugs can be responsible for it:

A. Timolol
B. Latanoprost
C. Brimonidine
D. Alphagan

**Core Concept:** Blepharoconjunctivitis is an inflammation of the eyelids and conjunctiva, respectively. In the context of anti-glaucoma medications, this may occur due to an allergic reaction or contact irritation caused by the drug.

**Why the Correct Answer is Right:** Timolol (Option A) is a beta-blocker that works by blocking the effects of catecholamines on beta-receptors. Although it is quite effective in lowering intraocular pressure (IOP), it has been known to cause local side effects such as blepharoconjunctivitis due to its prolonged contact with the ocular surface.

**Why Each Wrong Option is Incorrect:**

B. Latanoprost (Option B) is a prostaglandin F2 alpha analogue that promotes uveoscleral outflow of aqueous humor, thereby lowering IOP. Although it is a common choice for anti-glaucoma treatment, it is less likely to cause blepharoconjunctivitis due to its mechanism of action.

C. Brimonidine (Option C) is an alpha-2 adrenergic agonist that lowers IOP by increasing uveoscleral outflow and decreasing aqueous humor production. Although brimonidine is a potent anti-glaucoma drug, it has a lower risk of causing blepharoconjunctivitis compared to beta-blockers like Timolol.

D. Alphagan (Option D) is another alpha-2 adrenergic agonist similar to Brimonidine (Option C). It is also less likely to cause blepharoconjunctivitis compared to beta-blockers like Timolol (Option A).

**Clinical Pearl:** In general, alpha-2 agonists like Brimonidine and Alphagan are less likely to cause blepharoconjunctivitis compared to beta-blockers like Timolol. This is because alpha-2 agonists act on alpha-2 receptors, which are less likely to cause ocular surface irritation compared to beta-receptors targeted by beta-blockers. However, like with any medication, the risk of side effects cannot be completely ruled out, as individual responses vary.